Research & Development



  黎舟想了想,點頭道︰“對。”   葉紅玉耐心問道︰“他多大了?”超碰在线   老板指了透明塑料罐︰“就這個,比巴卜泡泡糖。”亚洲在线   刁明山對外人苛刻,但對著黎家小少爺極好說話,點頭笑道︰“好好,那就留在醫院,這次你們沒有性命危險就是祖宗保佑,老爺子昨天知道的時候嚇得不輕,唉!人平安就是最大的好消息了。”他轉頭跟小少爺說話,眼楮一直落在他臉上,視線在他一側臉頰上停留了片刻但是沒說什麼。   “我想了很久。”在线av   母子連心,他家小少爺做事怎麼會錯呢?

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo